HMGCR IMNM differs from the more common statin-induced myopathy, and importantly, from a clinical perspective, IMNM symptoms fail to resolve after discontinuation of the offending drug, consistently highlighted in case reports [4]. This evidence concerns the gene HMGCR and myopathy.